Trial intelligence / Profile preview

Nurse practitioner support for outpatient clozapine initiation and monitoring

NL-OMON20244Not yet recruiting

Sponsor
Rivierduinen
Start
Jun 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised, single-blind trial of clozapine in Schizophrenia Spectrum And Other Non-Affective Psychotic Disorders (2 arms), sponsored by Rivierduinen. Primary endpoints: Proportion of missed weekly white blood cell laboratory exams and Delay in white blood cell laboratory exams. Planned start Jun 2015; status: not yet recruiting.

02

Drugs

clozapine
03

Conditions

Schizophrenia Spectrum And Other Non-Affective Psychotic Disorders

Beyond the preview

Go deeper on NL-OMON20244.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20244.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call